← Back to Analyst Consensus 
ABBV Buy
AbbVie Inc.
Current Price —
Implied Upside —
Analysts 39
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 9 reiterations from 9 firms
Next Earnings
Oct 30, 2026 (4 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 23, 2026 | Goldman Sachs | maintain | Neutral → Neutral | $294 | 54% |
| Oct 21, 2026 | Barclays | maintain | Overweight → Overweight | $325 | 53% |
| Oct 13, 2026 | RBC Capital | reiterate | Outperform → Outperform | — | 55% |
| Oct 9, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Oct 9, 2026 | Guggenheim | reiterate | Buy → Buy | — | 52% |
| Oct 8, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Oct 8, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Oct 7, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Oct 6, 2026 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $320 | 55% |
| Sep 10, 2026 | HSBC | maintain | Buy → Buy | $315 | 53% |
| Aug 20, 2026 | Piper Sandler | maintain | Overweight → Overweight | $303 | 54% |
| Aug 17, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Aug 13, 2026 | Wolfe Research | upgrade | Peer Perform → Outperform | $300 | 54% |
| Aug 11, 2026 | BNP Paribas | maintain | Neutral → Neutral | $247 | 52% |
| Aug 10, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $260 | 58% |
| Aug 6, 2026 | Berenberg | maintain | Buy → Buy | $275 | 29% |
| Aug 5, 2026 | Erste Group | upgrade | Hold → Buy | $0 | 52% |
| Aug 4, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Aug 3, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Aug 3, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | $285 | 50% |
| Aug 3, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $296 | 54% |
| Jul 31, 2026 | TD Cowen | maintain | Buy → Buy | $280 | 54% |
| Jul 31, 2026 | William Blair | maintain | Buy → Buy | $0 | 48% |
| Jul 29, 2026 | Barclays | maintain | Overweight → Overweight | $300 | 53% |
| Jul 22, 2026 | Canaccord Genuity | maintain | Buy → Buy | $282 | 48% |
| Jul 15, 2026 | Citigroup | maintain | Neutral → Neutral | $260 | 54% |
| Jul 13, 2026 | UBS | maintain | Neutral → Neutral | $260 | 54% |
| Jul 13, 2026 | BMO Capital | maintain | Outperform → Outperform | $300 | 53% |
| Jul 10, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Jul 10, 2026 | RBC Capital | maintain | Outperform → Outperform | $280 | 55% |
| Jul 10, 2026 | Wells Fargo | maintain | Overweight → Overweight | $295 | 54% |
| Jul 9, 2026 | Guggenheim | maintain | Buy → Buy | $261 | 52% |
| Jul 9, 2026 | JP Morgan | maintain | Overweight → Overweight | $280 | 55% |
| Jul 6, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | $265 | 50% |
| Jun 23, 2026 | Piper Sandler | reiterate | Overweight → Overweight | $298 | 54% |
| Jun 23, 2026 | Canaccord Genuity | maintain | Buy → Buy | $273 | 48% |
| May 15, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $235 | 58% |
| May 14, 2026 | Piper Sandler | maintain | Overweight → Overweight | $298 | 54% |
| May 4, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $236 | 58% |
| May 1, 2026 | Guggenheim | reiterate | Buy → Buy | $249 | 52% |
| Apr 30, 2026 | Canaccord Genuity | maintain | Buy → Buy | $265 | 48% |
| Apr 30, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $278 | 54% |
| Apr 30, 2026 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $240 | 50% |
| Apr 23, 2026 | Piper Sandler | maintain | Overweight → Overweight | $294 | 54% |
| Apr 21, 2026 | Canaccord Genuity | initiate | — → Buy | $262 | 48% |
| Apr 10, 2026 | Guggenheim | maintain | Buy → Buy | $249 | 52% |
| Apr 8, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | $240 | 50% |
| Feb 25, 2026 | RBC Capital | initiate | — → Outperform | $260 | 55% |
| Feb 20, 2026 | Barclays | initiate | — → Overweight | $275 | 53% |
| Feb 18, 2026 | Piper Sandler | maintain | Overweight → Overweight | $299 | 54% |
Price Target Trend
Aug 23, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days